
FOXO4-DRI (FOXO4 D-Retro-Inverso Peptide)
品牌: Ponyon
FOXO4-DRI is an experimental research peptide studied for its potential roles in cellular senescence, FOXO4–p53 protein interactions, senescent-cell biology, apoptosis, and molecular mechanisms associated with tissue aging.
SKU FOXO4DRI-2MG_10 · 30 天内可退货
FOXO4-DRI, or FOXO4 D-Retro-Inverso Peptide, is an experimental peptide investigated in cellular senescence and senescent-cell biology research.
FOXO4 is a member of the Forkhead Box O family of transcription factors and is associated with multiple biological processes, including cellular stress responses, DNA-damage responses, cell-cycle regulation, and cell survival.
A major area of FOXO4-DRI research involves the interaction between FOXO4 and the p53 protein. In certain preclinical models, researchers have investigated how disrupting the FOXO4–p53 interaction may influence senescent-cell survival and apoptosis-related signaling.
FOXO4-DRI therefore provides an experimental tool for studying mechanisms involving cellular senescence, senescent-cell selectivity, p53 signaling, apoptosis, and tissue aging.
The peptide has also attracted interest in senolytic research, where investigators study relationships between the accumulation of senescent cells, age-associated tissue changes, and experimental strategies targeting senescent-cell biology.
Research involving FOXO4-DRI remains primarily experimental and preclinical. Current evidence does not establish that FOXO4-DRI safely or effectively eliminates senescent cells in humans, reverses human aging, extends lifespan, or treats age-related diseases.
寄往美国、加拿大、墨西哥与欧洲,标准运送满 $50 免运费,订单 1 个工作日内发出。
不满意?30 天内可全额退款,即使已经开封。
用户评价
暂无评价
来写下第一条评价吧。
完善你的方案
* 以上声明未经美国食品药品监督管理局(FDA)评估。本产品不用于诊断、治疗、治愈或预防任何疾病。孕期、哺乳期、服药或患有疾病者请先咨询医生。







